Industries & Sectors
Find covered US-listed Biotechnology stocks and compare their market caps, revenue, and cash flow.
Biotech stocks can include early-stage companies developing treatments and established businesses with products on the market. Their revenue and funding needs vary with the stage of development. Market cap provides a common starting point for comparing companies that have very different sales and cash flow.
Revenue can come from product sales, research partnerships, or milestone payments. A large payment in one period can make the trailing year's revenue look stronger than the recurring business. Filings describe the source of revenue and the development stage of each major program.
Negative free cash flow can reflect spending on trials, manufacturing, or a commercial launch. Compare cash and cash flow with the expected timing of those costs. New financing can change the share count, so the equity disclosures matter when comparing companies over time.
The screen uses FullRatio's Biotechnology industry and sorts by market cap from largest to smallest. Revenue and free cash flow cover the trailing 12 months.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.